世界のオーソバイオロジクス市場は2011年から2015年にかけて、CAGR7.1%で拡大する見込みです。人口高齢化に伴う関節炎や骨粗鬆症の増加、脊椎固定術におけるオーソバイオロジクスの利用増加などが市場の主な成長促進要因となっています。
当レポートでは、世界のオーソバイオロジクス市場の分析を行っており、市場規模とその予測、市場の成長要因や課題、主要ベンダーの分析などを盛り込んで、概略以下の構成でお届けします。
Abstract
TechNavio's analysts forecast the Global Orthobiologics market to grow at a CAGR of 7.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing incidence of arthritis and osteoporosis. The Global Orthobiologics market has also been witnessing the emergence of Nanotechnology and Tissue Engineering. However, lack of product availability for Bone Allografts could pose a challenge to the growth of this market.
TechNavio's report, the Global Orthobiologics Market 2011-2015, has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Bone Grafts, Demineralized Bone Matrix, Growth Factors, Visco-supplementation, and Cell-based markets landscape and their growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include Depuy Inc., Genzyme Corporation, Medtronic Inc., Smith & Nephew, Stryker Corporation, and Synthes Inc. Other vendors mentioned in the report: Angstrom Medica, ApaTech, Baxter International, Blackstone Medica, Encelle, Integra Lifesciences Corp., Kinetic, Landec, LifeCell, Lifecore Biomedical, NuVasive, Orthofix International N.V, OrthoMimetics, Orthovita, Osteotech Inc., Pioneer Surgical, Progentix, Orthobiology, Sanofi-Aventis, TiGenix, and Wright Medical Group Inc.
Key questions answered in this report:
- What will the market size be in 2015 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
- Market Overview
- Key Products
04. Market Landscape
- Market Size
- Key Market Segments
- Size of the Global Bone Grafts Market
- Key Market Segments of the Bone Grafts Market
- Key Customer Segments
- Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
- US
- Japan
- Germany
- Top Vendors in Leading Countries
07. Vendor Landscape
- Product Portfolio Matrix
- Major Deals among Vendors in the Global Orthobiologics Market
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
- Impact of Drivers on End-user Category
- Impact of Drivers on Geography
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
- 14.1. Medtronic Inc.
- Business Overview
- SWOT Analysis
- 14.2. Genzyme Corporation
- Business Overview
- SWOT Analysis
- 14.3. Synthes Inc.
- Business Overview
- SWOT Analysis
- 14.4. Smith and Nephew plc
- Business Overview
- SWOT Analysis
- 14.5. DePuy Inc. (Johnson & Johnson)
- Business Overview
- SWOT Analysis
- 14.6. Stryker Corporation
- Business Overview
- SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
- Exhibit 1: Global Orthobiologics Market by Market Segmentation
- Exhibit 2: Global Orthobiologics Market 2011-2015 (US$ million)
- Exhibit 3: Global Orthobiologics Market by Key Market Segmentation 2011
- Exhibit 4: Global Bone Grafts Market 2011-2015 (US$ million)
- Exhibit 5: Global Bone Grafts Market by Market Segmentation 2011
- Exhibit 6: Global Orthobiologics Market by Geographical Segmentation 2011
- Exhibit 7: Global Orthobiologics Market by Vendor Segmentation 2011
